Grifols is a prominent global healthcare company specializing in the development of plasma-derived medicines and biopharmaceuticals. Their innovative approach leverages extensive knowledge in plasma, diagnostics, and life sciences to create therapies that significantly enhance the quality of life for patients with chronic and rare diseases. The company emphasizes scientific innovation, focusing on understanding human health and researching potential treatments. Grifols is committed to ethical leadership and maintaining high standards of quality and safety, which are integral to their operations and product offerings.

In addition to their core biopharmaceuticals, Grifols actively invests in external innovation through partnerships and alliances, aiming to expand their therapeutic capabilities. Their global research centers, staffed by over 1,200 investigators, facilitate initiatives from early discovery to advanced clinical trials. Furthermore, Grifols places a strong emphasis on professional development through The Grifols Academy, which offers extensive training programs for both employees and external professionals in various fields, including plasmapheresis and transfusion medicine. This commitment to innovation and education underscores Grifols' mission to improve health outcomes and contribute positively to society.

Spain

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. A leader in essential plasma-derived medicines and other innovative biopharmaceutical solutions.

Grifols

Company Details